{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:30:53Z","timestamp":1795102253132,"version":"4.10.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This case report describes a 29-year-old female with recurrent T-cell Acute Lymphoblastic Leukemia who developed acute angle closure glaucoma (AACG) following daratumumab infusion. The patient, with a history of bone marrow transplantation and head-neck radiotherapy, experienced sudden eye pain and blurred vision minutes after treatment initiation. Ophthalmological examination revealed bilateral closed angles and elevated intraocular pressure. Ultrasound biomicroscopy showed ciliary malrotation and effusion, suggesting choroidal effusion secondary to daratumumab. The condition was successfully managed with topical medications and subsequent infusions were administered with atropine premedication, preventing recurrence. This case highlights bone marrow transplantation as a potential risk factor for daratumumab-induced AACG and demonstrates the effectiveness of atropinization in managing this complication.<\/jats:p>","DOI":"10.1186\/s12886-025-04214-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:27:45Z","timestamp":1751376465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Daratumumab-induced acute angle closure glaucoma: bone marrow transplantation as a possible risk factor and atropinization as a potential solution"],"prefix":"10.1186","volume":"25","author":[{"given":"Cansu","family":"Yuksel Elgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet F\u0131rat","family":"Atseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofeliya","family":"Mammadzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zcan","family":"Ocako\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"Spec Feature","key":"4214_CR1","first-page":"70","volume":"9","author":"LA Raedler","year":"2016","unstructured":"Raedler LA. Darzalex (daratumumab): first anti-CD38 monoclonal antibody approved for patients with relapsed multiple myeloma. Am Health Drug Benefits. 2016;9(Spec Feature):70\u20133.","journal-title":"Am Health Drug Benefits"},{"key":"4214_CR2","doi-asserted-by":"publisher","unstructured":"Lee AC, Greaves G, Lee R, et al. Bilateral angle closure following the infusion of a monoclonal antibody to treat relapsing multiple myeloma. J Glaucoma. 2018;27(9). https:\/\/doi.org\/10.1097\/IJG.0000000000000995.","DOI":"10.1097\/IJG.0000000000000995"},{"key":"4214_CR3","doi-asserted-by":"publisher","unstructured":"Strong A, Huvard M, Olson JL, Mark T, Capitena Young C. Daratumumab-induced choroidal effusion: a case report and review of the literature. Clin Lymphoma Myeloma Leuk. 2020;20(12). https:\/\/doi.org\/10.1016\/j.clml.2020.08.030.","DOI":"10.1016\/j.clml.2020.08.030"},{"issue":"2","key":"4214_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICU.0b013e32808738d5","volume":"18","author":"Y Lachkar","year":"2007","unstructured":"Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129\u201333. https:\/\/doi.org\/10.1097\/ICU.0b013e32808738d5.","journal-title":"Curr Opin Ophthalmol"},{"key":"4214_CR5","doi-asserted-by":"publisher","unstructured":"Edwards RG, Vanderhoof S, Palestine A, Seibold LK. Bilateral secondary angle closure during daratumumab infusion: a case report and review of the literature. J Glaucoma. 2020;29(8). https:\/\/doi.org\/10.1097\/IJG.0000000000001562.","DOI":"10.1097\/IJG.0000000000001562"},{"key":"4214_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijsu.2018.10.028","volume":"60","author":"RA Agha","year":"2018","unstructured":"Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler A, Orgill DP, For the SCARE group. The SCARE 2018 statement: updating consensus surgical case report (SCARE) guidelines. Int J Surg. 2018;60:132\u20136.","journal-title":"Int J Surg"},{"key":"4214_CR7","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.ajoc.2021.101079","volume":"22","author":"AO Saengsirinavin","year":"2021","unstructured":"Saengsirinavin AO, Wutthayakorn W, Chansangpetch S, Manassakorn A, Tantisevi V, Uaprasert N. Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion. Am J Ophthalmol Case Rep. 2021;22:101079.","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:27:45Z","timestamp":1751376465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4214"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04214-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval is necessary for a case report at Istanbul University-Cerrahpasa. The patient has given its consent to participate in this case study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish this case report has been obtained from the patient in writing. written informed consent was obtained from the authors for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}